| Closed |
SWOG-8218 |
Evaluation of Spirogermanium (NSC-192965) in Renal Cell Carcinoma |
7/21/1982 |
10/18/1983 |
|
|
Published
|
| Closed |
SWOG-9147 |
Evaluation of Tamoxifen in Desmoid Tumors, Phase II |
6/1/1992 |
8/1/1996 |
35% |
|
|
| Closed |
SWOG-7874 |
Evaluation of Tamoxifen in Stage III Malignant Melanoma |
11/27/1978 |
5/7/1980 |
|
|
|
| Closed |
SWOG-8415 |
Evaluation of Tamoxifen in Unresectable and Refractory Meningiomas, Phase II |
7/20/1984 |
7/1/1988 |
|
|
Published
|
| Closed |
SWOG-9242 |
Evaluation of Taxotere in Small Cell Lung Carcinoma, Phase II |
5/1/1993 |
1/15/1997 |
94% |
|
Published
|
| Closed |
SWOG-8954 |
Evaluation of the L-17M Protocol in the Management of Patients with Lymphoblastic Lymphoma |
4/15/1990 |
5/15/1997 |
74% |
|
|
| Closed |
SWOG-9348 |
Evaluation of the Standard BCNU/DTIC/Cisplatin/Tamoxifen Regimen in Disseminated Malignant Melanoma, Phase II |
4/15/1994 |
4/15/1995 |
85% |
|
Published
|
| Closed |
SWOG-9519 |
Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
6/15/1996 |
11/1/1997 |
68% |
|
Published
|
| Closed |
SWOG-9241 |
Evaluation of Topotecan in Colorectal Cancer, Phase II |
7/15/1993 |
11/15/1994 |
100% |
|
Published
|
| Closed |
SWOG-9339 |
Evaluation of Topotecan in Esophageal Carcinoma, Phase II |
3/1/1994 |
12/15/1995 |
100% |
|
Published
|
| Closed |
SWOG-9150 |
Evaluation of Topotecan in Gastric Cancer, Phase II |
7/15/1992 |
10/15/1993 |
57% |
|
Published
|
| Closed |
SWOG-9151 |
Evaluation of Topotecan in Hepatoma, Phase II |
2/1/1992 |
6/15/1993 |
100% |
|
Published
|
| Closed |
SWOG-9305 (CALGB-8984) |
Evaluation of Topotecan in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II |
1/15/1994 |
5/15/1995 |
75% |
|
Published
|
| Closed |
SWOG-9158 |
Evaluation of Trans Retinoic Acid and Alpha Interferon In Patients with Squamous Cell Carcinoma of the Lung (Stage IV) |
1/1/1993 |
5/1/1996 |
41% |
|
|
| Closed |
SWOG-8015 |
Evaluation of Two Combination Chemotherapy Programs Adriamycin and Cis-Platinum (AP) versus Adriamycin, Cis-Platinum plus VP 16-213 (VAP), in the Treatment of Extensive Squamous Cell Carcinoma of the… |
8/7/1980 |
1/31/1983 |
|
|
|
| Closed |
SWOG-8417/19 |
Evaluation of Two Consolidation Regimens in the Treatment of Adult Acute Lymphoblastic Leukemia |
6/14/1985 |
11/15/1991 |
100% |
|
Published
|
| Closed |
SWOG-9106 |
Evaluation of Two High Dose Chemotherapy Regimens With Autologous Bone Marrow and/or Stem Cell Support for Selected Patients With Advanced Ovarian Cancer, Phase II |
7/1/1993 |
11/15/1997 |
100% |
|
Published
|
| Closed |
SWOG-8001 |
Evaluation of Two Maintenance Regimens in the Treatment of Acute Lymphoblastic Leukemia in Adults |
7/10/1980 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-8703 |
Evaluation of Vinblastine and High-Dose Cis-Platinum in the Treatment of Advanced Non-Small Cell Lung Cancer |
9/1/1987 |
6/1/1989 |
|
|
Published
|
| Closed |
SWOG-8200 |
Evaluation of Vinblastine by Continuous Infusion for Advanced, Recurrent Endometrial Carcinoma |
3/31/1982 |
9/27/1985 |
|
|
Published
|
